CD177 and myeloproliferative disorder: HNA-2 deficiency, observed in 3-5% of the population, arises mainly from abnormal CD177 mRNA splicing or transcriptional silencing and is strongly associated with myeloproliferative disorders (MPDs) (112, 115).